BCLS II Equity Opportunities GP, LLC - 11 Jan 2024 Form 3 Insider Report for Solid Biosciences Inc. (SLDB)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: SLDB
Reported as of: 11 Jan 2024
Net transaction value: $0
SEC form: 3
Accepted by SEC: 19 Jan 2024, 19:23:27 UTC
Source filing: View source filing
Reporting owner signature: BCLS II EQUITY OPPORTUNITIES GP, LLC, By: Bain Capital Life Sciences Investors, LLC, its ultimate manager, By: /s/ Adam Koppel, Title: Partner

Key filing fact

BCLS II Equity Opportunities GP, LLC filed Form 3 for Solid Biosciences Inc. (SLDB) on 19 Jan 2024.

Key facts

This page summarizes BCLS II Equity Opportunities GP, LLC's Form 3 filing for Solid Biosciences Inc. (SLDB).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 19 Jan 2024, 19:23.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SLDB holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 904,160
Date: 11 Jan 2024
Ownership: See footnotes
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents 904,160 shares of Common Stock purchased by BCLS II Equity Opportunities, LP ("BCLS II Equity") directly from the Issuer in a private placement that closed on January 11, 2024.

Footnote F2

BCLS II Equity Opportunities GP, LLC ("BCLS II Equity GP") is the general partner of BCLS II Equity. As a result, BCLS II Equity GP may be deemed to share voting and dispositive power with respect to the securities held by BCLS II Equity. BCLS II Equity GP disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.